PerkinElmer Launches CE-Marked Infectious Disease Immunoassays on EUROIMMUN Random Access Instrument

ChLIA-based tests for detection of antibodies against Borrelia and Epstein-Barr Virus now available on EUROIMMUN RA Analyzer 10 System WALTHAM, Mass. – July 10, 2019 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the first two CE-marked chemiluminescence immunoassays (ChLIA) for the detection of anti-Borrelia (Lyme disease) and... Read more

Introducing Three New Formats for Antimicrobial Susceptibility Testing, Including New Compounds for Combatting Gram Negative and Multidrug-Resistant Infections

Introducing Three New Formats for Antimicrobial Susceptibility Testing, Including New Compounds for Combatting Gram Negative and Multidrug-Resistant Infections New microbroth dilution plates provide gold standard-level(1) minimum inhibitory concentration (MIC) accuracy using first- and second-line treatment options LENEXA, Kan., July 10, 2019 /PRNewswire/ — Comprehensive antimicrobial susceptibility testing (AST) for Gram negative and multidrug-resistant organisms (MDRO),... Read more

FBI Approves Thermo Fisher Scientific Forensic Sequencing Solution for National DNA Index System

FBI Approves Thermo Fisher Scientific Forensic Sequencing Solution for National DNA Index System Decision enables human identification labs to upload genetic profiles to national database using Applied Biosystems Precision ID panel for mitochondrial DNA analysis SAN FRANCISCO, July 9, 2019 /PRNewswire/ — The U.S. Federal Bureau of Investigation (FBI) has approved Thermo Fisher Scientific’s Applied Biosystems... Read more

Scale-up: Oxford Nanopore’s new high-tech factory comes online

Mon 8th July 2019 8th July 2019, Oxford, UK: Oxford Nanopore has started high-tech, automated manufacturing processes at its new factory in Oxford, UK. The MinION building is a bespoke, state-of-the-art, high-tech manufacturing facility that brings new, highly automated production processes to the manufacturing of consumable flow cells for Oxford Nanopore’s novel, real-time DNA/RNA sequencing... Read more

New England Biolabs, Inc. opens eighth subsidiary in Australia

Ipswich, MA (July 1, 2019) – New England Biolabs (NEB®), a world leader in the production of reagents for the life science industry, extended its global subsidiary network with the opening of New England Biolabs Australia Pty Ltd. Australia’s Life Sciences industry is home to more than 230,000 life science researchers, working towards advancing discoveries... Read more

IDT and 3CR pool expertise to provide a custom genotyping solution for low- to high-throughput screening

Jul 2, 2019 New high-performance, cost-effective PACE SNP assays will lower the cost and improve the reliability of SNP or indel screening CORALVILLE, IA (July 2, 2019) – In the latest collaboration in a series to advocate for genomics research, Integrated DNA Technologies (IDT) is teaming up with 3CR Bioscience (3CR) to widen access to quality custom solutions for genotyping screening.... Read more

Thermo Fisher Scientific Completes Sale of Anatomical Pathology Business to PHC Holdings Corporation

WALTHAM, Mass., June 28, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has completed the previously announced sale of its Anatomical Pathology business to PHC Holdings Corporation, a leading global healthcare company providing innovative solutions, for approximately $1.14 billion in cash. The Anatomical Pathology... Read more

Illumina Files Patent Infringement Suits Related to BGI in Switzerland, Turkey and the US

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed three additional patent infringement suits relating to BGI’s sequencing products, including the BGISeq-500, MGISeq-2000, and related chemistry reagents. The first complaint was filed against Complete Genomics, Inc. and other BGI entities in the United States District Court for the Northern District of California... Read more

IDT signs strategic partnership with Chinese medical sequencing firm ChosenMed

Jun 27, 2019 Partnership strengthens IDT’s position as an NGS leader in China CORALVILLE, IA (June 27, 2019) – Integrated DNA Technologies (IDT) announces that is has entered into a strategic cooperation with ChosenMed Technology (Beijing) Co., Ltd (ChosenMed), a medical sequencing firm focused on personalized medicine and transformation healthcare in China. As part of the collaboration, IDT... Read more